4//SEC Filing
McKinley Kate 4
Accession 0000950170-23-071475
CIK 0001856725other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:05 PM ET
Size
7.8 KB
Accession
0000950170-23-071475
Insider Transaction Report
Form 4
McKinley Kate
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-12-16+250,000→ 250,000 totalExercise: $2.84Exp: 2033-05-21→ Class A Common Stock (250,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-16−250,000→ 0 totalExercise: $4.13Exp: 2033-05-21→ Class A Common Stock (250,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on May 22, 2024; and 1/48th of the shares subject to the option vest monthly over the remaining three years.
- [F2]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001979211
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:05 PM ET
- Size
- 7.8 KB